Kaplan–Meier survival curves revealed that a significant survival benefit was achieved in the mice treated with oHSV-D11mt and anti-PD-L1 compared to the mice treated with either oHSV-D11mt or anti-PD-L1 alone in both 005 murine glioma and DB7 BCBM tumor-bearing immunocompetent mice (Figure 6K). The gene discussed is CD274; the disease is neoplasm.